The firms will collaborate on Summit’s experimental new medicine as well as researching how it could be combined with Astra’s treatments.
Back to Business
Business
September 29, 2026 at 8:20 AM
AstraZeneca invests £1.5bn into US firm Summit for cancer drug tie-up
The Independent Business
Excerpt from The Independent Business.